Donate

Consumers hoping a couple of recent policy proposals might lower prices for their prescription drugs may be out of luck, at least for now.  Earlier this year, the Trump administration had proposed a rule that would have required prescription drug manufacturers to disclose list prices for drugs advertised on TV. ...
There is clear evidence the pharmaceutical industry manipulates well-intentioned laws to increase prices and profits. We’ll use two laws as our case studies, the Orphan Drug Act of 1983 and the Hatch-Waxman Act of 1984 which jumpstarted the generic drug industry. The first was designed to give incentives to drug...
Tarbell is highlighting the government fines and penalties businesses pay when they engage in fraudulent or criminal behavior. Often, these fines are just a small part of the firms’ annual revenue and don’t actually serve as a deterrent. To these companies, it’s just the cost of doing business. International company...
Thirty-six state attorneys general and others allege that the manufacturer of Suboxone, a balm for America’s opioid crisis, gamed regulators and manipulated the market to overcharge consumers.
Addressing the problem will require private and public sector to agree on causes and solutions.
Axelrod said that Medicare for All has “become a phrase as much as anything else.”
The Food and Drug Administration is stopping more packages at the border. Many are ordered by Americans trying to save money on medications.
Were it not for the business practices of some of the biggest corporations in America that profit from the manufacture and distribution of massive quantities of opioids, many of those we have lost likely would still be with us. How are those big corporations responding? In one notable case...
The pharmaceutical industry doesn’t just contribute to patient groups or the lawmakers themselves through campaign contributions to assert influence. It floods the U.S. Capitol with lobbyists. A Tarbell analysis of lobbying disclosures found that the leading drugmakers that make up the Pharmaceutical Research and Manufacturers Association, and the association itself, have spent...
David Lichtenstein A new treatment could extend David’s life by 33%. But he can’t afford to take it. David Lichtenstein has ALS, also known as Lou Gehrig’s disease, and likely has only 3 to 5 years to live. This summer, the FDA approved a new treatment called Redicava that could extend...
Open enrollment is over and the flood of advertisements for Medicare Advantage plans has ended for another year. I’m happy to report that, once again, I’ve managed to avoid signing up for one of those plans. For those who aren’t familiar with Medicare Advantage...
A retired Tennessee physician and professor watches his state shred the medical safety net of his state. Just when I thought things couldn’t get much worse for the TennCare program, they did. (TennCare is Tennessee’s Medicaid managed care program.) First, Medicaid has not been expanded under the Affordable Care Act in...
An Appalachian physician explains how just five insurance powers control most of the market and what that means for patients.
With Congress set to debate “Medicare-for-all,” Tarbell examines efforts by health insurers to take over past health care reforms.
My former colleagues undoubtedly where cheering when they heard Sen. Michael Bennet (D-Colo.) come to the defense of private health insurers and trash the idea of improving and expanding Medicare to cover all Americans.
This New York City subway ad recently caught my attention: “When researching hospitals, consider how much research they do.” The ad for Mt. Sinai Health System advised riders that the research “we do today drives medicine we will do tomorrow,” and the hospital system was proud that it ranked...
The Pharmaceutical Research and Manufacturers of America, the main trade association for the drug industry, wrote $14.3 million in checks in 2015 to a panoply of nonprofit think tanks, disease advocacy groups and charities. The money is spread around liberally to win friends, to win influence, and to win the...
Big Pharma dresses wolves in sheep's clothing to keep drug prices high. Don't be deceived. Learn how to sniff them out.